VRTX
2026Q2AMCVertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY
Street
Consensus EPS4.15
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.5%
IV front—
P/C full—
P/C front—
Features as of2026-08-03
Run-up
Close—
Ret 5d-1.7%
Ret 10d-2.0%
Ret 20d-11.1%
Ret 30d+4.2%
Actual EPS
4.20Beat
Estimated EPS4.15
Actual revenue
3.3B
Surprise %+1.2%
Beat / missBeat
Beat streak 42
Beat streak 82
Reaction
1-day stock reaction+1.6%
Implied vs actual
Implied 2.5%Actual 0.1%
Gap reaction+0.1%
Day result+1.7%
Next-day upYes
Realized / IV0.05×
Post tape
Post 5d+10.6%
Post 10d+10.3%
Post volume2.0M
Vol ×10d1.51×
Vol ×20d1.39×
Post range4.8%